RLAY - Relay Therapeutics Inc


10.69
0.550   5.145%

Share volume: 5,665,512
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$10.14
0.55
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-02-2024 08-06-2024 11-06-2024 02-26-2025 05-05-2025 11-06-2025 02-26-2026
Total revenue 10.007 M 0.000 0.000 0.000 7.679 M 0.000 6.999 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 10.007 M 0.000 0.000 0.000 7.679 M 0.000 6.999 M
    -100.00% nan% nan%   -100.00% inf%  
Operating expenses 102.202 M 112.131 M 96.369 M 84.979 M 92.548 M 80.391 M 67.630 M
Selling general and admin 19.799 M 20.139 M 19.750 M 16.904 M 18.739 M 12.129 M 12.215 M
Research and development 82.403 M 91.992 M 76.619 M 68.075 M 73.809 M 68.262 M 55.415 M
Total expenses 102.202 M 100.757 M 96.369 M 84.979 M 92.548 M 80.391 M 67.630 M
    -1.41% -4.36% -11.82% 8.91% -13.14% -15.87%  
Operating income -92.195 M -100.757 M -96.369 M -84.979 M -84.869 M -80.391 M -60.631 M
Ebit -92.195 M -100.759 M -96.379 M -84.978 M -84.878 M -80.556 M -60.600 M
Pretax income -81.387 M -92.212 M -88.105 M -76.004 M -77.065 M -74.149 M -54.890 M
    13.30% -4.45% -13.73% 1.40% -3.78% -25.97%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -81.387 M 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%            
Net income -81.387 M -92.212 M -88.105 M -76.004 M -77.065 M -74.149 M -54.890 M
    -13.30% 4.45% 13.73% -1.40% 3.78% 25.97%